We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Banc of California
BANC
$3.29B
| $221K | ﹤0.01% |
15,964
-272
| -2% | -$4.06K |
|
1677
Rayonier
RYN
$6.48B
| $221K | ﹤0.01% |
7,733
-5,139
| -40% | -$137K |
|
1678
Under Armour
UAA
$3.1B
| $221K | ﹤0.01% |
10,455
-13,679
| -57% | -$287K |
|
1679
American Vanguard Corp
AVD
$74.4M
| $219K | ﹤0.01% |
12,720
-1,620
| -11% | -$28.6K |
|
1680
EastGroup Properties
EGP
$11.6B
| $219K | ﹤0.01% |
+1,964
| New | +$204K |
|
1681
Under Armour Class C
UA
$3.02B
| $218K | ﹤0.01% |
11,531
-14,035
| -55% | -$265K |
|
1682
Arista Networks
ANET
$220B
| $217K | ﹤0.01% |
11,056
-11,760
| -52% | -$187K |
|
1683
Powell Industries
POWL
$8.77B
| $217K | ﹤0.01% |
24,543
-1,080
| -4% | -$10.6K |
|
|
ROCC
1684
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $217K | ﹤0.01% |
4,918
+821
| +20% | +$44K |
|
1685
AngioDynamics
ANGO
$571M
| $214K | ﹤0.01% |
+9,343
| New | +$203K |
|
1686
MaxLinear
MXL
$7.77B
| $214K | ﹤0.01% |
8,392
-2,612
| -24% | -$57.1K |
|
|
MLNX
1687
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $214K | ﹤0.01% |
1,809
-1,117,521
| -100% | -$112M |
|
|
PEI
1688
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $214K | ﹤0.01% |
2,271
+675
| +42% | +$66.7K |
|
1689
Pathward Financial
CASH
$1.87B
| $213K | ﹤0.01% |
+10,845
| New | +$237K |
|
1690
Eagle Bancorp
EGBN
$822M
| $213K | ﹤0.01% |
+4,240
| New | +$231K |
|
|
FARO
1691
DELISTED
Faro Technologies
FARO
| $213K | ﹤0.01% |
+4,840
| New | +$214K |
|
|
RFP
1692
DELISTED
Resolute Forest Products Inc.
RFP
| $213K | ﹤0.01% |
26,925
+4,909
| +22% | +$41.1K |
|
|
CONE
1693
DELISTED
CyrusOne Inc Common Stock
CONE
| $213K | ﹤0.01% |
4,067
-11,977
| -75% | -$627K |
|
1694
Blackbaud
BLKB
$1.42B
| $212K | ﹤0.01% |
+2,658
| New | +$195K |
|
1695
Silicon Laboratories
SLAB
$7.16B
| $212K | ﹤0.01% |
+2,625
| New | +$218K |
|
1696
AMERISAFE
AMSF
$583M
| $210K | ﹤0.01% |
+3,537
| New | +$210K |
|
1697
Enterprise Financial Services Corp
EFSC
$2.4B
| $210K | ﹤0.01% |
+5,139
| New | +$221K |
|
1698
Kite Realty
KRG
$5.97B
| $210K | ﹤0.01% |
13,154
+2,152
| +20% | +$34.1K |
|
1699
Harmonic Inc
HLIT
$1.3B
| $208K | ﹤0.01% |
38,343
-1,303
| -3% | -$6.91K |
|
1700
Pacific Biosciences
PACB
$429M
| $208K | ﹤0.01% |
28,706
-343,969
| -92% | -$2.49M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.